PAPER Coleman MP, Höke A
SEARCH RESULTS
358 RESULTS
PAPER Sambashivan S, Freeman MR
SARM1 signaling mechanisms in the injured nervous system.
Curr Opin Neurobiol. 2021 Aug;69:247-255. Epub 2021 Jun 25 PubMed.Biocuration Scientist
JOB 2025-03-07 Employer AlzForum Foundation Inc. Contact Apply here. Description The biocuration scientist is responsible for the ongoing curation of scientific databases and directories in the Alzforum website (www.alzforum.org). Alzforum provides a high-quality scien
NB-4746
THERAPEUTICS Nura Bio™ Inc. Small Molecule Other In August 2023, Nura Bio began Phase 1 with an ascending-dose safety trial in 66 healthy volunteers. Single doses of 50, 100, 175, 300, 450, and 600 mg, or 10 days of repeated dosing were compared to placebo. Besides sa
Russell Swerdlow on A positron emission tomography tracer for the imaging of oxidative stress in the central nervous system.
COMMENT A PET ligand that reveals oxidative stress in the human brain will facilitate work within the AD research field on a number of levels. It will help investigators get a glimpse into oxidative stress in the brains of AD patients. From there, investigators c
Aoife Murray
, United Kingdom
PAPER Wen S, Ju Z, Wang Y, Zuo CT, Sun X, Zheng T
FRET Nanosensor Based on DNA Tetrahedron for Visualizing PLD3 Fluctuation in Mouse Models of Alzheimer's Disease.
ACS Appl Mater Interfaces. 2025 Mar 5;17(9):13461-13470. Epub 2025 Feb 19 PubMed.PAPER Ludolph A, Klose V, Dreyhaupt J, Del Tredici K, Braak H
The deltoid muscle and the pattern of paresis in ALS.
J Neurol. 2025 Mar 6;272(3):253. PubMed.PAPER Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Al-Gareeb AI, Albuhadily AK, Mohammed SG
Role of RhoA-ROCK signaling inhibitor fasudil in Alzheimer disease.
Behav Brain Res. 2025 Mar 3;484:115524. Epub 2025 Mar 3 PubMed.PAPER Preziuso A, Serfilippi T, Toujani M, Terenzi V, Amoroso S, Magi S, Lariccia V, Piccirillo S
A non-redundant role of EAAT3 for ATP synthesis mediated by GDH in dopaminergic neuronal cells: a new avenue for glutamate metabolism and protection in Parkinson's disease.
FEBS J. 2025 Mar 5; Epub 2025 Mar 5 PubMed.PAPER Qiang Q, Skudder-Hill L, Toyota T, Huang Z, Wei W, Adachi H, Alzheimer’s Disease Neuroimaging Initiative
CSF α-synuclein aggregation is associated with APOE ε4 and progressive cognitive decline in Alzheimer's disease.
Neurobiol Aging. 2025 Feb 27;150:9-18. Epub 2025 Feb 27 PubMed.PAPER Pikija S, Toma A, Radlberger R, Griessenauer CJ, Hecker C, Trinka E, Ki PH, Kraus T, Weis S, Wermer MJ, van Etten ES, Kaushik K
Iatrogenic Cerebral Amyloid Angiopathy in Patients Treated With Cadaveric Dura Mater During Childhood Neurosurgery: A Retrospective Cohort Study.
Eur J Neurol. 2025 Mar;32(3):e70091. PubMed.PAPER Alpaugh M, Lantero-Rodriguez J, Benedet AL, Manseau U, Boutin M, Maiuri M, Denis HL, Masnata M, Fazal SV, Chouinard S, Rosa-Neto P, Barker RA, Blennow K, Zetterberg H, Labib R, Cicchetti F
Tau levels in platelets isolated from Huntington's disease patients serve as a biomarker of disease severity.
J Neurol. 2025 Mar 6;272(3):254. PubMed.PAPER Wang Z, Cheng C, Duan H, Chen X, Li W, Ma F, Li Z, Yan J, He R, Li Z, Yang M, Huang Z, Chen Y, Huang G
Association of whole blood multi-micronutrients with mild cognitive impairment in Chinese older adults: a matched case-control study.
Eur J Nutr. 2025 Mar 6;64(3):111. PubMed.PAPER Antonioni A, Raho EM, Di Lorenzo F, Manzoli L, Flacco ME, Koch G
Blood phosphorylated Tau217 distinguishes amyloid-positive from amyloid-negative subjects in the Alzheimer's disease continuum. A systematic review and meta-analysis.
J Neurol. 2025 Mar 6;272(3):252. PubMed.Current Filters
- Date Range : Past 7 Days x